Acute myeloid leukemia (AML) has a poor prognosis, especially in elderly and relapsed/refractory patients, with 5‑year ...

A comprehensive approach is necessary for navigating the highly heterogeneous nature of leukemia across different age ...

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...

Relapsed acute myeloid leukemia (AML) is when cancer returns after a period of remission. Refractory AML means cancer has not responded to multiple rounds of treatment. Both can affect your treatment ...

Study from Japan shows near-tripling over 30-year period ...

Macrophages, much like Alice of “Alice in Wonderland,” recognize and consume tumor cells that display “eat me” surface markers. However, tumor cells can evade detection by macrophages if they ...